Oxford Biomedica Share News (OXB)

Oxford Biomedica Information

Buy OXB Shares
Add OXB to Watchlist
Add OXB to Alert

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 331.00

Bid: 328.00

Ask: 333.00

Change: 10.50 (3.28%)

Spread: 5.00 (1.524%)

Open: 316.50

High: 333.00

Low: 315.00

Prev. Close: 320.50

Last checked at -

TOP NEWS: Centrica warms up for FTSE 100 as Royal Mail sent packing

Wed, 01st Jun 2022 18:21

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, June 20 after completing its quarterly review.

-------

FTSE 100 Adds:

-------

Centrica PLC

Unite Group PLC

-----

FTSE 100 Deletes:

-------

Royal Mail PLC

ITV PLC

-------

FTSE 250 Adds:

-------

Asos PLC

Bank of Georgia Group PLC

Merchants Trust PLC

Supermarket Income REIT PLC

Target Healthcare REIT PLC

-------

FTSE 250 Deletes:

-------

Baillie Gifford US Growth Trust PLC

Oxford BioMedica PLC

PureTech Health PLC

Rank Group PLC

Trustpilot PLC

-------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

More News

1 Dec 2020 14:29

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

9 Nov 2020 10:01

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

9 Nov 2020 09:16

Oxford Biomedica strikes collaboration agreement with PhoreMost

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has inked a discovery collaboration agreement with UK-based biopharmaceutical company PhoreMost.

4 Nov 2020 09:40

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

30 Oct 2020 08:47

Oxford Biomedica partner delays Parkinson's disease treatment trial

(Sharecast News) - Gene and cell therapy group Oxford Biomedica said on Friday that partner Axovant Gene Therapies had pushed out the start date for its trial into a Parkinson's disease treatment.

23 Oct 2020 15:15

UK DIRECTOR DEALINGS SUMMARY: Liontrust Chiefs Bank GBP1.6 Million

6 Oct 2020 14:19

Oxford BioMedica Notes Positive Follow-Up Data From AXO-Lenti-PD

6 Oct 2020 09:44

Another Manufacturing Suite At Oxford Biomedica's Oxbox Gets Approval

6 Oct 2020 07:55

LONDON BRIEFING: BHP To Increase Stake In Gulf Of Mexico Development

6 Oct 2020 07:43

LONDON MARKET PRE-OPEN: Watches Of Switzerland Ups Full-Year Guidance

6 Oct 2020 07:03

Oxford Biomedica new manufacturing suite approved

(Sharecast News) - Oxford Biomedica said it had received government approval for a fourth manufacturing suite within its Oxbox facility which will be used to develop a potential Covid-19 vaccine.

17 Sep 2020 10:43

Oxford Biomedica Burns Bright Amid AstraZeneca Vaccine Deal

17 Sep 2020 08:35

LONDON MARKET OPEN: Stocks Tumble In US Fed's Wake And Ahead Of BoE

17 Sep 2020 07:52

LONDON MARKET PRE-OPEN: Next Raises Full-Year Profit Outlook

17 Sep 2020 07:01

Oxford Biomedica sees swing to FY profit on Covid vaccine hopes

(Sharecast News) - Drugs maker Oxford Biomedica, which has partnered with pharma giant AstraZeneca to develop a Covid-19 vaccine, said it expected higher second half revenues to push it to a low-to-single digit full year profit.

Latest Share Chat

Oxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Centrica warms up for FTSE 100 as Royal Mail sent packing

Login to your account

Quickpicks are a member only feature

Login to your account